Hong Zhe
- Cancer Research top 10%
- Molecular Biology top 10%
- Genomics, phytochemicals, and oxidative stress 6
-
- Colorectal Cancer Surgical Treatments 3
- Inflammatory Biomarkers in Disease Prognosis 3
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 2
- Toxicology top 10%
-
- Stroke Rehabilitation and Recovery 2
-
- Esophageal Cancer Research and Treatment 2
-
- Advanced Radiotherapy Techniques 2
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hong Zhe
24 papers receiving 973 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 266
- Molecular Biology 745
- Oncology 185
- Toxicology 19
- Immunology 68
Countries citing papers authored by Hong Zhe
This map shows the geographic impact of Hong Zhe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Zhe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Zhe more than expected).
Fields of papers citing papers by Hong Zhe
This network shows the impact of papers produced by Hong Zhe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Zhe. The network helps show where Hong Zhe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong Zhe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 5 | |
| 5 | 2020 | 9 | |
| 6 | The role of neutrophil-to-lymphocyte ratio (NLR) in predicting small bowel toxicity and outcome for rectal cancer patients who received chemoradiotherapy | 2019 | 1 |
| 7 | 2019 | 10 | |
| 8 | 2018 | 27 | |
| 9 | 2018 | 53 | |
| 10 | 2018 | 294 | |
| 11 | 2016 | 13 | |
| 12 | 2015 | 24 | |
| 13 | 2015 | 34 | |
| 14 | 2014 | 67 | |
| 15 | 2014 | 207 | |
| 16 | 2013 | 6 | |
| 17 | 2012 | 0 | |
| 18 | 2011 | 45 | |
| 19 | Association of the C3435T polymorphism in the multidrug resistance gene 1 and response to antiepileptic drug treatment in epilepsy patients | 2007 | 1 |
| 20 | An intronic cholesterol 24S-hydroxylase polymorphism associated with Alzheimer disease | 2006 | 1 |
About Hong Zhe
Hong Zhe is a scholar working on Oncology, Rehabilitation and Toxicology, having authored 26 papers that have together received 981 indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (6 papers), Colorectal Cancer Surgical Treatments (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Stroke Rehabilitation and Recovery (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Esophageal Cancer Research and Treatment (2 papers), Advanced Radiotherapy Techniques (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (266 citations), Molecular Biology (745 citations) and Oncology (185 citations). Hong Zhe has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ren Zhao, Yanyang Wang, Yanyang Wang, Yinxue Yang, Zhoulan Bai, Zhijun Zhao, Di Xia, Shun Zhou, Shu-Feng Zhou and Zhixu He.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.